Abstract
Objective: To investigate the presence of cCMV infection and the CMV-DNA virus in the newborns who applied for newborn hearing
 screening test (NHST) and CMV-DNA viruria with physical, mental-motor development and hearing status of cCMV cases in the
 second year of age.
 Patients and Methods: CMV-DNA was investigated in 1150 newborns’ oral swabs (0-21 days) by polymerase chain reaction kit and
 urine of patients with positive CMV-DNA in saliva. Transient Evoked Otoacoustic Emission test was performed for NHST.
 Results: CMV-DNA was posititve in saliva of 38 (3.3%) newborns and urine of 10 out of 37 newborns. The prevalence of cCMV
 was 0.87% (95% CI=0.697-1.042). All newborns passed the NHST. In newborns with cCMV:jaundice in 60% (6/10), low birthweight
 in 40% (4/10), small for gestational age in 50% (5/10) of them. Jaundice was the most significant variable (P
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
